PAVmed (NASDAQ:PAVM) Trading 9.4% Higher

Share on StockTwits

PAVmed Inc (NASDAQ:PAVM)’s share price traded up 9.4% during mid-day trading on Friday . The company traded as high as $0.93 and last traded at $0.93, 663,134 shares traded hands during mid-day trading. An increase of 193% from the average session volume of 226,476 shares. The stock had previously closed at $0.85.

Separately, Maxim Group reiterated a “buy” rating and issued a $3.00 target price on shares of PAVmed in a research report on Friday, November 22nd.

The stock has a 50-day simple moving average of $0.89 and a 200-day simple moving average of $0.99.

Institutional investors have recently added to or reduced their stakes in the business. Glassman Wealth Services grew its holdings in shares of PAVmed by 54.9% during the third quarter. Glassman Wealth Services now owns 32,149 shares of the company’s stock worth $31,000 after purchasing an additional 11,400 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of PAVmed by 174.4% during the second quarter. Vanguard Group Inc. now owns 1,123,483 shares of the company’s stock worth $1,281,000 after purchasing an additional 714,077 shares during the last quarter. BlackRock Inc. bought a new stake in shares of PAVmed during the second quarter worth about $59,000. Finally, CWM LLC grew its holdings in shares of PAVmed by 206.7% during the second quarter. CWM LLC now owns 46,000 shares of the company’s stock worth $52,000 after purchasing an additional 31,000 shares during the last quarter. Hedge funds and other institutional investors own 7.31% of the company’s stock.

About PAVmed (NASDAQ:PAVM)

PAVmed Inc operates as a medical device company in the United States. The company's lead product pipeline includes CarpX, a percutaneous device to treat carpal tunnel syndrome; EsoCheck, an non-invasive cell collection device and DNA biomarkers to detect esophageal cancer precursor; PortIO, an implantable intraosseous vascular access device; and DisappEAR, an antimicrobial resorbable ear tube.

Featured Story: How to trade on quiet period expirations

Receive News & Ratings for PAVmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed and related companies with MarketBeat.com's FREE daily email newsletter.